@prefix ns1: <http://schema.org/> .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=118> a ns1:MedicalCondition ;
    ns1:alternateName "Beta-mannosidase deficiency" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:118" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2931893" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E77.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0342849" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:118" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "869" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D044905" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D044905" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "869" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E77.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "248510" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2931893" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "248510" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0342849" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "Beta-mannosidosis is a very rare lysosomal storage disease characterized by developmental delay of varying severity and hearing loss, but that can manifest a wide phenotypic heterogeneity." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "118" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Beta-mannosidosis" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Beta-mannosidosis" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=141> a ns1:MedicalCondition ;
    ns1:alternateName "ACY2 deficiency",
        "Aminoacylase 2 deficiency",
        "Aspartoacylase deficiency",
        "Spongy degeneration of the brain" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0206307" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C3542499" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10067608" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5984" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D017825" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "271900" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10067608" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5984" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "271900" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0206307" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C3542499" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:141" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D017825" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:141" ;
            ns1:codingSystem "ORPHAcode" ] ;
    ns1:description "Canavan disease (CD) is a neurodegenerative disorder; its spectrum varies between severe forms with leukodystrophy, macrocephaly and severe developmental delay, and a very rare mild/juvenile form characterized by mild developmental delay." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "141" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Canavan disease" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Canavan disease" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166029> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "609324" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "609324" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166029" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1836315" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166029" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q77.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q77.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1836315" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia is a rare primary bone dysplasia characterized by severe, early-onset dysplasia of the proximal femurs, with almost complete absence of the secondary ossification centers and abnormal development of the femoral necks (short and broad with irregular metaphyses). It is associated with gait abnormality, mild short stature, arthralgia, joint stiffness with limited mobility of the hips and irregular acetabula, and hip and knee pain. Coxa vara and mild spinal changes are also associated." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166029" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166035> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "Q87.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q87.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "250410" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166035" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1855188" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166035" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1855188" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "250410" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "Brachydactyly-short stature-retinitis pigmentosa syndrome is a rare, genetic, congenital limb malformation syndrome characterized by mild to severe short stature, brachydactyly, and retinal degeneration (usually retinitis pigmentosa), associated with variable intellectual disability, developmental delays, and craniofacial anomalies." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166035" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Brachydactyly-short stature-retinitis pigmentosa syndrome" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Brachydactyly-short stature-retinitis pigmentosa syndrome" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166038> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "250230" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166038" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q78.5" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "250230" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166038" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1855217" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1855217" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q78.5" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "Metaphyseal chondrodysplasia, Kaitila type is a rare multiple metaphyseal dysplasia disease characterized by disproportionate short stature, short limbs and digits, tracheobronchial malacia and progressive thoracolumbar scoliosis. Radiographic imaging shows progression from marked metaphyseal dysplasia of tubular bones in childhood to short and broad bones with mild dysplasia of the joints in adulthood. There have been no further descriptions in the literature since 1982." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166038" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Metaphyseal chondrodysplasia, Kaitila type" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Metaphyseal chondrodysplasia, Kaitila type" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166063> a ns1:MedicalCondition ;
    ns1:alternateName "Fatal infantile encephalopathy with olivopontocerebellar hypoplasia",
        "Olivopontocerebellar hypoplasia",
        "PCH4" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "225753" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C536716" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "343" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166063" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166063" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q04.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q04.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "225753" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1856974" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C536716" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1856974" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "343" ;
            ns1:codingSystem "GARD" ] ;
    ns1:description "A severe, genetic form of pontocerebellar hypoplasia (PCH) characterized by delayed neocortical maturation with underdeveloped cerebral hemispheres and pontocerebellar hypoplasia and a severely affected vermis. Clinically, the disorder manifests with prenatal onset of polyhydramnios and contractures followed by hypertonia, severe clonus, primary hypoventilation leading to an early postnatal death." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166063" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Pontocerebellar hypoplasia type 4" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Pontocerebellar hypoplasia type 4" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166068> a ns1:MedicalCondition ;
    ns1:alternateName "Fetal-onset olivopontocerebellar hypoplasia",
        "PCH5" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C1857762" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "610204" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1857762" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166068" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10709" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166068" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10709" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "610204" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "" ;
    ns1:epidemiology "Prevalence : " ;
    ns1:identifier "166068" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Pontocerebellar hypoplasia type 5" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Pontocerebellar hypoplasia type 5" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166073> a ns1:MedicalCondition ;
    ns1:alternateName "Fatal infantile encephalopathy with mitochondrial respiratory chain defects",
        "PCH6" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C1969084" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10710" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10710" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166073" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "611523" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166073" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "611523" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q04.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C548074" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1969084" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q04.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C548074" ;
            ns1:codingSystem "MeSH" ] ;
    ns1:description "A rare, genetic form of pontocerebellar hypoplasia (PCH) characterized by neocortical and severe cerebral cortical atrophy associated with pontocerebellar hypoplasia with the pons and cerebellum equally affected. Clinically the disorder manifests at birth with hypotonia, clonus, epilepsy, impaired swallowing and from infancy by progressive microcephaly, spasticity and lactic acidosis." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166073" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Pontocerebellar hypoplasia type 6" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Pontocerebellar hypoplasia type 6" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166078> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "193400" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "193400" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D056725" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1264039" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166078" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1264039" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166078" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D056725" ;
            ns1:codingSystem "MeSH" ] ;
    ns1:description "A form of von Willebrand disease (VWD) characterized by a bleeding disorder associated with a partial, quantitative plasmatic deficiency of an otherwise structurally and functionally normal von Willebrand factor (VWF)." ;
    ns1:epidemiology "Prevalence : 1-5 / 10 000" ;
    ns1:identifier "166078" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 1" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 1" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166081> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1264040" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D056728" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166081" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1264040" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D056728" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166081" ;
            ns1:codingSystem "ORPHAcode" ] ;
    ns1:description "A form of von Willebrand disease (VWD) characterized by a bleeding disorder associated with a qualitative deficiency and functional anomalies of the Willebrand factor (VWF). Depending on the type of functional abnormalities, this form is classified as type 2A, 2B, 2M or 2N." ;
    ns1:epidemiology "Prevalence : 1-9 / 1 000 000" ;
    ns1:identifier "166081" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166084> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166084" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166084" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1282968" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1282968" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (VWF) for platelets and the subendothelium caused by a deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage, etc.)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "166084" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2A" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2A" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166087> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166087" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1282971" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1282971" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166087" ;
            ns1:codingSystem "ORPHAcode" ] ;
    ns1:description "A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with increased affinity of the Willebrand factor (VWF) for platelets leading to rapid clearance of both the platelets (increasing the risk of thrombocytopenia) and VWF from the plasma. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage, etc.)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "166087" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2B" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2B" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166090> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C1282974" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1282974" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166090" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166090" ;
            ns1:codingSystem "ORPHAcode" ] ;
    ns1:description "A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with decreased affinity of the Willebrand factor (VWF) for platelets or collagen in the absence of any deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage, etc.)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "166090" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2M" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2M" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166093> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C1282975" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "613554" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166093" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166093" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1282975" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with a marked decrease in the affinity of the Willebrand factor (VWF) for factor VIII (FVIII). Abnormal bleeding manifestations are less frequent in this VWD subtype than in other forms of the disease. The disease manifests mainly as soft tissue bleeding (haematoma, post-operative bleeding, etc.)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "166093" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2N" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 2N" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166096> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "277480" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1264041" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166096" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1264041" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "277480" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D056729" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166096" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D056729" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D68.0" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "A form of von Willebrand disease (VWD) characterized by a bleeding disorder associated with a total or near-total absence of Willebrand factor (VWF) in the plasma and cellular compartments, also leading to a profound deficiency of plasmatic factor VIII (FVIII). It is the most severe form of VWD." ;
    ns1:epidemiology "Prevalence : 1-9 / 1 000 000" ;
    ns1:identifier "166096" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 3" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Von Willebrand disease type 3" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166100> a ns1:MedicalCondition ;
    ns1:alternateName "AD OSMED",
        "Stickler syndrome type 3",
        "Stickler syndrome, non-ocular type" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C537494" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "184840" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1861481" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q87.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5021" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1861481" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166100" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q87.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C537494" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5021" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "184840" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166100" ;
            ns1:codingSystem "ORPHAcode" ] ;
    ns1:description "A rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by craniofacial dysmorphism (midface hypoplasia, depressed nasal bridge, small nose with upturned tip, cleft palate, Pierre Robin sequence), bilateral, pronounced sensorineural hearing loss, and skeletal/joint anomalies (including spondyloepiphyseal dysplasia, arthralgia/arthropathy), in the absence of ocular abnormalities." ;
    ns1:epidemiology "Prevalence : " ;
    ns1:identifier "166100" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Autosomal dominant otospondylomegaepiphyseal dysplasia" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Autosomal dominant otospondylomegaepiphyseal dysplasia" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166105> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "618855" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "G71.3" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166105" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166105" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "618855" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "G71.3" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "FASTKD2-related infantile mitochondrial encephalomyopathy is a rare, genetic, mitochondrial oxidative phosphorylation disorder characterized by infantile-onset encephalomyopathy presenting with developmental delay, slowly progressive hemiplegia, intractable epileptic seizures and asymmetrical brain atrophy with dilatation of the ipsilateral ventricle system. Additional features include optic atrophy, mildly increased plasma and/or CSF lactate and decreased cytochrome c oxidase activity in skeletal muscle biopsy." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166105" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "FASTKD2-related infantile mitochondrial encephalomyopathy" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "FASTKD2-related infantile mitochondrial encephalomyopathy" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166108> a ns1:MedicalCondition ;
    ns1:alternateName "Intellectual disability-hypotonia-facial dysmorphism syndrome" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166108" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "612292" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166108" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q87.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10358" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q87.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "612292" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10358" ;
            ns1:codingSystem "GARD" ] ;
    ns1:description "Intellectual disability, Birk-Barel type is a rare, genetic, syndromic intellectual disability characterized by congenital central hypotonia, developmental delay, moderate to severe intellectual disability and subtle dysmorphic features which evolve over time (dolichocephaly, myopathic facies, ptosis, short and broad philtrum, tented upper lip vermillion, palatal anomalies, mild micro- and/or retrognathia). Patients present reduced facial movements, lethargy, weak cry, transient neonatal hypoglycemia, severe feeding difficulties and failure to thrive. Dysphagia, particularly of solid food, asthenic body build, joint contractures and scoliosis are additional features." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166108" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Intellectual disability, Birk-Barel type" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Intellectual disability, Birk-Barel type" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166113> a ns1:MedicalCondition ;
    ns1:alternateName "Acrokeratosis of Bazex",
        "Acrokeratosis paraneoplastica",
        "Acrokeratosis paraneoplastica of Bazex" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166113" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0346104" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0346104" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0406355" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166113" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0406355" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "Bazex syndrome is a rare paraneoplastic syndrome characterized by acral psoriasiform lesions." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "166113" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Bazex syndrome" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Bazex syndrome" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166119> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0029455" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0029455" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1833699" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "166700" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q78.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166119" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "166700" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166119" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1833699" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "Q78.8" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "A rare primary bone dysplasia characterized by multiple, small, round to ovoid osteosclerotic foci with a predilection for the epiphyses and metaphyses of long tubular bones as well as the pelvis, scapula, carpal, and tarsal bones. The condition is usually clinically silent and discovered only incidentally, although some patients may experience mild articular pain with or without joint effusion. Bone strength is normal." ;
    ns1:epidemiology "Prevalence : " ;
    ns1:identifier "166119" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Isolated osteopoikilosis" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Isolated osteopoikilosis" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166260> a ns1:MedicalCondition ;
    ns1:alternateName "Capdepont teeth",
        "DGI-2",
        "DI-2",
        "Dentinogenesis imperfecta, Shields type 2" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "K00.5" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "125490" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166260" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "12796" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "605594" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "605594" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166260" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2973527" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "12796" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2973527" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "125490" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K00.5" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "Dentinogenesis imperfecta type 2 (DGI-2) is a rare, severe form of dentinogenesis imperfecta (DGI, see this term) and is characterized by weakness and discoloration of all teeth." ;
    ns1:epidemiology "Prevalence : 1-5 / 10 000" ;
    ns1:identifier "166260" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Dentinogenesis imperfecta type 2" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Dentinogenesis imperfecta type 2" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=166265> a ns1:MedicalCondition ;
    ns1:alternateName "Dentinogenesis imperfecta, Shields type 3" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166265" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:166265" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10144" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K00.5" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10144" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "125500" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "125500" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K00.5" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0399378" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0399378" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "Dentinogenesis imperfecta type 3 (DGI-3) is a rare, severe form of dentinogenesis imperfecta (DGI, see this term) characterized by opalescent primary and permanent teeth, marked attrition, large pulp chambers, multiple pulp exposure and shell teeth radiographically (i.e. teeth which appear hollow due to dentin hypotrophy)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "166265" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Dentinogenesis imperfecta type 3" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Dentinogenesis imperfecta type 3" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=206> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "K50.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K50.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K50.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K50.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K50.8" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:206" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:206" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "K50.1" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "" ;
    ns1:epidemiology "Prevalence : " ;
    ns1:identifier "206" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "NON RARE IN EUROPE: Crohn disease" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "NON RARE IN EUROPE: Crohn disease" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=213> a ns1:MedicalCondition ;
    ns1:alternateName "Protein defect of cystin transport" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0010690" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "219900" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6236" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "219800" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E72.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10011777" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E72.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "219750" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:213" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D003554" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:213" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D003554" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10011777" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "219900" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "219800" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6236" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "219750" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0010690" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "A rare lysosomal disease characterized by an accumulation of cystine inside the lysosomes, causing damage in different organs and tissues, particularly in the kidneys and eyes. Three clinical forms have been described: nephropathic infantile, nephropathic juvenile and ocular." ;
    ns1:epidemiology "Prevalence : 1-9 / 100 000" ;
    ns1:identifier "213" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Cystinosis" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Cystinosis" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=333> a ns1:MedicalCondition ;
    ns1:alternateName "Acid ceramidase deficiency",
        "Farber lipogranulomatosis" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D055577" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2936785" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6426" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C537075" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:333" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0268255" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "228000" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "228000" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C537075" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6426" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:333" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2936785" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0268255" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D055577" ;
            ns1:codingSystem "MeSH" ] ;
    ns1:description "A subcutaneous tissue disease characterized by a spectrum of clinical signs ranging from the classical triad of painful and progressively deformed joints, subcutaneous nodules, and progressive hoarseness (due to laryngeal involvement) that presents in infancy, to varying phenotypes with respiratory and neurologic involvement." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "333" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Farber disease" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Farber disease" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=349> a ns1:MedicalCondition ;
    ns1:alternateName "Alpha-L-fucosidase deficiency" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "230000" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6473" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "230000" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6473" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D005645" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E77.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D005645" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E77.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0016788" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:349" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0016788" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:349" ;
            ns1:codingSystem "ORPHAcode" ] ;
    ns1:description "Fucosidosis is an extremely rare lysosomal storage disorder characterized by a highly variable phenotype with common manifestations including neurologic deterioration, coarse facial features, growth retardation, and recurrent sinopulmonary infections, as well as seizures, visceromegaly, angiokeratoma and dysostosis." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "349" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Fucosidosis" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Fucosidosis" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=365> a ns1:MedicalCondition ;
    ns1:alternateName "Alpha-1,4-glucosidase acid deficiency",
        "GSD due to acid maltase deficiency",
        "GSD type 2",
        "GSD type II",
        "Glycogen storage disease type 2",
        "Glycogen storage disease type II",
        "Glycogenosis due to acid maltase deficiency",
        "Glycogenosis type 2",
        "Glycogenosis type II",
        "Pompe disease" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "232300" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017921" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D006009" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D006009" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232300" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:365" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5714" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017921" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:365" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053185" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053185" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5714" ;
            ns1:codingSystem "GARD" ] ;
    ns1:description "A rare lysosomal storage disease characterized by lysosomal accumulation of glycogen particularly in skeletal, cardiac, and respiratory muscles, as well as the liver and nervous system, due to acid maltase deficiency. The clinical spectrum comprises infantile-onset disease with severe hypertrophic cardiomyopathy, generalized muscle weakness, poor feeding and failure to thrive, and respiratory insufficiency, and late-onset disease manifesting before or after twelve months of age without cardiomyopathy, with proximal muscle weakness and respiratory insufficiency." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "365" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to acid maltase deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to acid maltase deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=366> a ns1:MedicalCondition ;
    ns1:alternateName "Amylo-1,6-glucosidase deficiency",
        "Cori disease",
        "Cori-Forbes disease",
        "Forbes disease",
        "GDE deficiency",
        "GSD due to glycogen debranching enzyme deficiency",
        "GSD type 3",
        "GSDIII",
        "Glycogen storage disease type 3",
        "Glycogen storage disease type III",
        "Glycogenosis due to glycogen debranching enzyme deficiency",
        "Glycogenosis type 3",
        "Glycogenosis type III",
        "Limit dextrinosis" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0017922" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053250" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:366" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053250" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2936915" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017922" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232400" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232400" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "9442" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:366" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "9442" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2936915" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "Glycogen debranching enzyme (GDE) deficiency, or glycogen storage disease type 3 (GSD 3), is a form of glycogen storage disease characterized by severe muscle weakness and hepatopathy." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "366" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to glycogen debranching enzyme deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to glycogen debranching enzyme deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=367> a ns1:MedicalCondition ;
    ns1:alternateName "Amylopectinosis",
        "Andersen disease",
        "GSD due to glycogen branching enzyme deficiency",
        "GSD type 4",
        "GSD type IV",
        "Glycogen storage disease type 4",
        "Glycogen storage disease type IV",
        "Glycogenosis due to glycogen branching enzyme deficiency",
        "Glycogenosis type 4",
        "Glycogenosis type IV" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C1563715" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:367" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232500" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017923" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "263570" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "2520" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:367" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053249" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "263570" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017923" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053249" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1563715" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "2520" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232500" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "Glycogen branching enzyme (GBE) deficiency (Andersen's disease or amylopectinosis), or glycogen storage disease type 4 (GSD4), is a rare and severe form of glycogen storage disease which accounts for approximately 3% of all the glycogen storage diseases (see these terms)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "367" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to glycogen branching enzyme deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to glycogen branching enzyme deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=368> a ns1:MedicalCondition ;
    ns1:alternateName "GSD due to muscle glycogen phosphorylase deficiency",
        "GSD type 5",
        "GSD type V",
        "Glycogen storage disease type 5",
        "Glycogen storage disease type V",
        "Glycogenosis due to muscle glycogen phosphorylase deficiency",
        "Glycogenosis type 5",
        "Glycogenosis type V",
        "McArdle disease",
        "Myophosphorylase deficiency" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0017924" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6528" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10018462" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2936916" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:368" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D006012" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2936916" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D006012" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C537276" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:368" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017924" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232600" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C537276" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6528" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10018462" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232600" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "Myophosphorylase deficiency (McArdle's disease), or glycogen storage disease type 5 (GSD5) , is a severe form of glycogen storage disease characterized by exercise intolerance." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "368" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to muscle glycogen phosphorylase deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to muscle glycogen phosphorylase deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=369> a ns1:MedicalCondition ;
    ns1:alternateName "GSD due to liver glycogen phosphorylase deficiency",
        "GSD type 6",
        "GSD type VI",
        "Glycogen storage disease type 6",
        "Glycogen storage disease type VI",
        "Glycogenosis due to liver glycogen phosphorylase deficiency",
        "Glycogenosis type 6",
        "Glycogenosis type VI",
        "Hepatic glycogen phosphorylase deficiency",
        "Hepatic phosphorylase deficiency",
        "Hers disease",
        "Liver glycogen phosphorylase deficiency" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0017925" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6529" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053240" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053240" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232700" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017925" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:369" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:369" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232700" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6529" ;
            ns1:codingSystem "GARD" ] ;
    ns1:description "Liver phosphorylase deficiency, or glycogen storage disease type 6b (Hers' disease, GSD 6b) is a benign and rare form of glycogen storage disease." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "369" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to liver glycogen phosphorylase deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to liver glycogen phosphorylase deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=371> a ns1:MedicalCondition ;
    ns1:alternateName "GSD due to muscle phosphofructokinase deficiency",
        "GSD type 7",
        "GSD type VII",
        "Glycogen storage disease type 7",
        "Glycogen storage disease type VII",
        "Glycogenosis due to muscle phosphofructokinase deficiency",
        "Glycogenosis type 7",
        "Glycogenosis type VII",
        "Tarui disease" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0017926" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5686" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053241" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:371" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E74.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0017926" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232800" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:371" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10053241" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5686" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "232800" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "Muscle phosphofructokinase (PFK) deficiency (Tarui's disease), or glycogen storage disease type 7 (GSD7), is a rare form of glycogen storage disease characterized by exertional fatigue and muscular exercise intolerance. It occurs in childhood." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "371" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to muscle phosphofructokinase deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Glycogen storage disease due to muscle phosphofructokinase deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=447> a ns1:MedicalCondition ;
    ns1:alternateName "Marchiafava-Micheli disease",
        "PNH" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "615399" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "615399" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "300818" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0024790" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "7337" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "7337" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:447" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D59.5" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:447" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D006457" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10034042" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10034042" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D006457" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0024790" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "300818" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D59.5" ;
            ns1:codingSystem "ICD-10" ] ;
    ns1:description "Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematopoietic stem cell disorder characterized by corpuscular hemolytic anemia, bone marrow failure and frequent thrombotic events." ;
    ns1:epidemiology "Prevalence : 1-9 / 100 000" ;
    ns1:identifier "447" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Paroxysmal nocturnal hemoglobinuria" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Paroxysmal nocturnal hemoglobinuria" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=487> a ns1:MedicalCondition ;
    ns1:alternateName "GALC deficiency",
        "Galactocerebrosidase deficiency",
        "Galactosylceramidase deficiency",
        "Globoid cell leukodystrophy" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "10023492" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10023492" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0023521" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "611722" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6844" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "611722" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:487" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6844" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "245200" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:487" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0023521" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "245200" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "A rare lysosomal disorder that affects the white matter of the central and peripheral nervous systems characterized by neurodegeneration with severity depending on the age of onset (infantile, late-infantile, juvenile, adolescent and adulthood)." ;
    ns1:epidemiology "Prevalence : 1-9 / 100 000" ;
    ns1:identifier "487" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Krabbe disease" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Krabbe disease" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=535> a ns1:MedicalCondition ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:535" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D008178" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "L93.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "L93.0" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6225" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0024137" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "6225" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10056509" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D008178" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "L93.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:535" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "L93.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10056509" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "L93.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "L93.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0024137" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "Rare cutaneous lupus erythematosus (CLE) is an autoimmune disease that denotes a heterogeneous spectrum of clinical manifestations affecting the skin and can be divided into 4 categories: acute CLE (ACLE); subacute CLE (SCLE); chronic CLE (CCLE; the most diverse form); and intermittent CLE (ICLE). CLE can either occur alone or associated with systemic lupus erythematosus (SLE)." ;
    ns1:epidemiology "Prevalence : 1-5 / 10 000" ;
    ns1:identifier "535" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Rare cutaneous lupus erythematosus" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Rare cutaneous lupus erythematosus" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=583> a ns1:MedicalCondition ;
    ns1:alternateName "ARSB deficiency",
        "ASB deficiency",
        "Arylsulfatase B deficiency",
        "MPS6",
        "MPSVI",
        "Maroteaux-Lamy disease",
        "Mucopolysaccharidosis type VI",
        "N-acetylgalactosamine 4-sulfatase deficiency" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0026709" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "253200" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D009087" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:583" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D009087" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E76.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0026709" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10056892" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:583" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "7095" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10056892" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "253200" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E76.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "7095" ;
            ns1:codingSystem "GARD" ] ;
    ns1:description "Mucopolysaccharidosis type 6 (MPS 6) is a lysosomal storage disease with progressive multisystem involvement, associated with a deficiency of arylsulfatase B (ASB) leading to the accumulation of dermatan sulfate." ;
    ns1:epidemiology "Prevalence : 1-9 / 1 000 000" ;
    ns1:identifier "583" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Mucopolysaccharidosis type 6" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Mucopolysaccharidosis type 6" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=585> a ns1:MedicalCondition ;
    ns1:alternateName "Juvenile sulfatidosis, Austin type",
        "MSD",
        "Mucosulfatidosis" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "C0268263" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1720864" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0268263" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:585" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "272200" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5061" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:585" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C1720864" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5061" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E75.2" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "272200" ;
            ns1:codingSystem "OMIM" ] ;
    ns1:description "Multiple sulfatase deficiency (MSD) is a very rare and fatal lysosomal storage disease characterized by a clinical phenotype that combines the features of different sulfatase deficiencies (whether lysosomal or not) that can have neonatal (most severe), infantile (most common) and juvenile (rare) presentations with manifestations including hypotonia, coarse facial features, mild deafness, skeletal anomalies, ichthyosis, hepatomegaly, developmental delay, progressive neurologic deterioration and hydrocephalus." ;
    ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
    ns1:identifier "585" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Multiple sulfatase deficiency" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Multiple sulfatase deficiency" ] .

<http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=93> a ns1:MedicalCondition ;
    ns1:alternateName "Aspartylglucosaminidase deficiency" ;
    ns1:code [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:93" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E77.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "208400" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D054880" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0268225" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "ORPHA:93" ;
            ns1:codingSystem "ORPHAcode" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "D054880" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10068220" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C538402" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2931840" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5854" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C2931840" ;
            ns1:codingSystem "UMLS" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C538402" ;
            ns1:codingSystem "MeSH" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "10068220" ;
            ns1:codingSystem "MedDRA" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "208400" ;
            ns1:codingSystem "OMIM" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "5854" ;
            ns1:codingSystem "GARD" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "E77.1" ;
            ns1:codingSystem "ICD-10" ],
        [ a ns1:MedicalCode ;
            ns1:codeValue "C0268225" ;
            ns1:codingSystem "UMLS" ] ;
    ns1:description "An autosomal recessive lysosomal storage disease belonging to the oligosaccharidosis group (also called glycoproteinosis)." ;
    ns1:epidemiology "Prevalence : Unknown" ;
    ns1:identifier "93" ;
    ns1:name [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Aspartylglucosaminuria" ],
        [ a ns1:PronounceableText ;
            ns1:inLanguage "EN" ;
            ns1:textValue "Aspartylglucosaminuria" ] .

